Taken together, in addition to activation of the ROS-JNK signaling cascade, inactivation of NF-κB and Nrf2 might also contribute to anti-leukemia activity of DS/Cu toward leukemia stem-like cells. The gene discussed is NFE2L2; the disease is leukemia.